Advertisement

Mobile Banner
Mobile Banner
Mobile Banner
Loading...

Incyte Corporation

INCYNASDAQ
Healthcare
Biotechnology
$101.73
$0.00(0.00%)
U.S. Market is Open • 15:50

Incyte Corporation (INCY) Stock Overview

Explore Incyte Corporation’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap20.2B
P/E Ratio15.51
EPS (TTM)$6.41
ROE0.29%
Fundamental Analysis

AI Price Forecasts

1 Month$93.27
3 Months$103.89
1 Year Target$109.17

INCY Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Incyte Corporation (INCY) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 47.51, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $109.17.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 15.51 and a market capitalization of 20.2B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-0.40%
5-Day Change
-0.15%
1-Month Change
-1.27%
3-Month Change
-0.43%
6-Month Change
17.54%
Year-to-Date (YTD) Change
-0.10%
1-Year Change
41.94%
3-Year Change
29.09%
5-Year Change
26.78%
All-Time (Max) Change
5303.73%

Contact Information

302 498 6700
1801 Augustine Cut-Off, Wilmington, DE, 19803

Company Facts

26,170 Employees
IPO DateNov 4, 1993
CountryUS
Actively Trading

Frequently Asked Questions